“…p-Synephrine binds up to 10 times more readily to adrenergic receptors in rodents than humans (Carpene' et al, 1999(Carpene' et al, , 2014Mercader et al, 2011), which can explain small cardiovascular effects in some animal studies at very high doses (Hansen et al, 2012(Hansen et al, , 2013. p-Synephrine, the primary active constituent in bitter orange extracts, at least in part, exerts its effects through multiple mechanisms including its binding to β-3 adrenergic receptors that regulate lipid and carbohydrate metabolism, NMUR2s, and AMP-activated protein kinase, cAMP, and Ca(2+)-dependent mechanisms (Hong et al, 2012;Zheng et al, 2014;de Oliveira et al, 2014). Because p-synephrine exhibits little or no binding to α-1, α-2, β-1, and β-2 adrenergic receptors, p-synephrine exerts metabolic enhancement without acting as a central nervous system or cardiovascular stimulant at commonly used doses and therefore does not increase heart rate or blood pressure.…”